Skip to main content

Advertisement

Log in

Outcomes of rectal cancer patients with a positive pathological circumferential resection margin

  • Original Article
  • Published:
Langenbeck's Archives of Surgery Aims and scope Submit manuscript

Abstract

Purpose

Evidence-based management of positive pathological circumferential resection margin (pCRM) following preoperative radiation and an adequate rectal resection for rectal cancers is lacking.

Methods

Retrospective analysis of prospectively maintained single-centre institutional database was done to study the patterns of failure and management strategies after a rectal cancer surgery with a positive pCRM.

Results

A total of 86 patients with rectal adenocarcinoma with a positive pCRM were identified over 8 years (2011–2018). Majority had low-lying rectal cancers (90.7%) and were operated after preoperative radiotherapy (95.3%). Operative procedures included abdomino-perineal resections, inter-sphincteric resections, low anterior resections and pelvic exenteration in 61 (70.9%), 9 (10.5%), 11(12.8%) and 5 (5.8%) patients respectively. A total of 83 (96.5%) received chemotherapy as the sole adjuvant treatment modality while 2 patients (2.3%) were given post-operative radiotherapy and 1 patient underwent revision surgery. A total of 53 patients (61.6%) had recurrence, with 16 (18.6%), 20 (23.2%), 8(9.3%) and 9 (10.5%) patients having locoregional, systemic, peritoneal and simultaneous local-systemic relapse. Systemic recurrences were more often detected either by surveillance in an asymptomatic patient (20.1%) while local (13.1%) and peritoneal (13.2%) recurrences were more often symptomatic (p = 0.000). The 2-year overall survival (OS) and disease-free survival (DFS) of the cohort was 82.4% and 74.0%. Median local recurrence-free survival (LRFS) was 10.3 months.

Conclusions

Patients with a positive pCRM have high local and distal relapse rates. Systemic relapses are more often asymptomatic as compared to peritoneal or locoregional relapse and detected on follow-up surveillance. Hence, identification of such recurrences while still salvageable via an intensive surveillance protocol is desirable.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

Data availability

The data used in the manuscript will be available upon request from the corresponding author.

Code availability

Not applicable.

Abbreviations

APR:

Abdomino-perineal resection

LAR:

Low anterior resection

ISR:

Inter-sphincteric resection

pCRM:

Pathological circumferential resection margin

TME:

Total mesorectal excision

b-TME:

Beyond TME

e-TME:

Extended TME

MRF:

Mesorectal fascia

References

  1. van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM-K, Putter H, Wiggers T et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre randomised controlled TME trial. Lancet Oncol 12(6):575–82

    Article  Google Scholar 

  2. The Beyond TME Collaborative (2013) Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planes: Guidelines. Br J Surg 100(8):1009–1014

    Article  Google Scholar 

  3. Battersby NJ, How P, Moran B, Stelzner S, West NP, Branagan G et al (2016) Prospective validation of a low rectal cancer magnetic resonance imaging staging system and development of a local recurrence risk stratification model: The MERCURY II Study. Ann Surg 263(4):751–760

    Article  Google Scholar 

  4. Rickles AS, Dietz DW, Chang GJ, Wexner SD, Berho ME, Remzi FH et al (2015) High Rate of positive circumferential resection margins following rectal cancer surgery: a call to action. Ann Surg 262(6):891–898

    Article  Google Scholar 

  5. Carlson RV, Boyd KM, Webb DJ. The revision of the Declaration of Helsinki: past, present and future. :19.

  6. Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303–312

    Article  Google Scholar 

  7. Tekkis PP, Heriot AG, Smith J, Thompson MR, Finan P, Stamatakis JD et al (2005) Comparison of circumferential margin involvement between restorative and nonrestorative resections for rectal cancer. Colorectal Dis Off J Assoc Coloproctology G B Irel 7(4):369–374

    CAS  Google Scholar 

  8. de Paul TR, Augestad KM, Kiran RP, Keller DS. Management of the positive pathologic circumferential resection margin in rectal cancer: a national cancer database (NCDB) study. Eur J Surg Oncol. 2020 Aug;S0748798320306600.

  9. Xu Z, Mohile SG, Tejani MA, Becerra AZ, Probst CP, Aquina CT et al (2017) Poor compliance with adjuvant chemotherapy use associated with poorer survival in patients with rectal cancer: an NCDB analysis: Adjuvant Chemotherapy in Rectal Cancer. Cancer 123(1):52–61

    Article  CAS  Google Scholar 

  10. the AIMS Academy Clinical Research Network, Mari GM, Maggioni D, Crippa J, Costanzi ATM, Scotti MA et al (2019) Compliance to adjuvant chemotherapy of patients who underwent surgery for rectal cancer: report from a multi-institutional research network. World J Surg 43(10):2544–51

    Article  Google Scholar 

  11. Marijnen CAM, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JHJM et al (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol 55(5):1311–1320

    Article  CAS  Google Scholar 

  12. Kim JH (2017) Controversial issues in radiotherapy for rectal cancer: a systematic review. Radiat Oncol J 35(4):295–305

    Article  CAS  Google Scholar 

  13. Kim Y, Kim DY, Kim TH, Kim SY, Baek JY, Kim MJ et al (2018) Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis. Br J Radiol 91(1092):20180143

    Article  Google Scholar 

  14. Denost Q, Assenat V, Vendrely V, Celerier B, Rullier A, Laurent C, et al. Oncological strategy following R1 sphincter-saving resection in low rectal cancer after chemoradiotherapy. Eur J Surg Oncol. 2021 Feb;S0748798321000615.

  15. Goéré D, Glehen O, Quenet F, Guilloit J-M, Bereder J-M, Lorimier G, et al. Second-look surgery plus hyperthermic intraperitoneal chemotherapy versus surveillance in patients at high risk of developing colorectal peritoneal metastases (PROPHYLOCHIP–PRODIGE 15): a randomised, phase 3 study. Lancet Oncol. 2020 Jul;S1470204520303223.

  16. MERCURY Study Group (2006) Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 333(7572):779

    Article  Google Scholar 

  17. Saklani AP (2014) Magnetic resonance imaging in rectal cancer: a surgeon’s perspective. World J Gastroenterol 20(8):2030

    Article  Google Scholar 

  18. Balbaa MA, Elkady N, Abdelrahman EM (2020) Predictive factors of positive circumferential and longitudinal margins in early T3 colorectal cancer resection. Int J Surg Oncol 27(2020):1–8

    Google Scholar 

  19. Tamhankar AS, Ingle P, Engineer R, Bal M, Ostwal V, Saklani A (2016) Signet ring colorectal carcinoma: do we need to improve the treatment algorithm? World J Gastrointest Oncol 8(12):819

    Article  Google Scholar 

  20. Shinde RS, Katdare N, Kumar NAN, Bhamre R, Desouza A, Ostwal V et al (2018) Impact of histological subtype on treatment outcomes in locally advanced rectal adenocarcinoma treated with neoadjuvant chemoradiation. Acta Oncol 57(12):1721–1723

    Article  Google Scholar 

  21. Rullier A, Gourgou-Bourgade S, Jarlier M, Bibeau F, Chassagne-Clément C, Hennequin C et al (2013) Predictive factors of positive circumferential resection margin after radiochemotherapy for rectal cancer: the french randomised trial ACCORD12/0405 PRODIGE 2. Eur J Cancer 49(1):82–89

    Article  Google Scholar 

  22. Bhamre R, Mitra A, Tamankar A, Desouza A, Saklani A (2019) Impact of length of distal margin on outcomes following sphincter preserving surgery for middle and lower third rectal cancers. Indian J Surg Oncol 10(2):335–341

    Article  Google Scholar 

  23. Kazi M, Bhamre R, DeSouza A, Ostwal V, Engineer R, Patel S et al (2021) Long-term oncological outcomes of the sphincter preserving total mesorectal excision with varying distal resection margins. J Surg Oncol 22(jso):26467

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

The authorship has been decided in accordance with CRediT taxonomy.

Corresponding author

Correspondence to Avanish Saklani.

Ethics declarations

Ethics approval

Not applicable as retrospective analysis.

Consent to participate

Not applicable.

Consent for publication.

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Patel, S., Kazi, M., Desouza, A.L. et al. Outcomes of rectal cancer patients with a positive pathological circumferential resection margin. Langenbecks Arch Surg 407, 1151–1159 (2022). https://doi.org/10.1007/s00423-021-02392-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00423-021-02392-6

Keywords

Navigation